Taro Pharmaceutical Industries

NYSE:TARO

42.25

+0.06 (+0.14%)

4:02:42 PM EDT: $42.25 0.00 (0.00%)

Market Cap (Intraday)	1.59B
Current PE	34.74
Forward PE	38.41
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$156.06 Million
Adjusted EPS	$0.31

See more estimates

10-Day MA	$42.16
50-Day MA	$42.13
200-Day MA	$39.07

See more pivots

Taro Pharmaceutical Industries Stock, NYSE:TARO

14 Hakitor Street, 14 Hakitor Street, Haifa Bay, Haifa 2624761

Israel

Phone: +972.4.847.5700

Number of Employees: 1554

http://www.taro.com

Description

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.